Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Accord Biopharma Inc recalls IMULDOSA

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of assurance of Sterility:
Products
  • IMULDOSA
Company
Accord Biopharma Inc
Where it was sold

US Nationwide.

Nationwide

Units affected
326 vials
About this recall
IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactured at: Catalent Indiana, LLC, 1300 S. Patterson Drive, Bloomington, IN 47403, USA, NDC 69448-019-26.